Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
2024 | 2023 | ||||||||||||||||||||||||||||||
Actual
(GAAP) | SBC |
Other non-
operating adjustments |
Adjusted
(Non-GAAP) |
Actual
(GAAP) | SBC |
Other non-
operating adjustments |
Adjusted
(Non-GAAP) | ||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||
Revenue | $ | 558,647 | $ | - | $ | - | $ | 558,647 | $ | 387,402 | $ | - | $ | - | $ | 387,402 | |||||||||||||||
Cost of revenue | (277,908 | ) | (2,020 | ) | - | (275,888 | ) | (190,263 | ) | (838 | ) | - | (189,425 | ) | |||||||||||||||||
Gross profit | 280,739 | (2,020 | ) | - | 282,759 | 197,139 | (838 | ) | - | 197,977 | |||||||||||||||||||||
Gross margin | 50.3 | % | 0.4 | % | - | 50.6 | % | 50.9 | % | 0.2 | % | - | 51.1 | % | |||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||
Sales and marketing | (47,067 | ) | (8,645 | ) | - | (38,422 | ) | (37,579 | ) | (3,405 | ) | - | (34,174 | ) | |||||||||||||||||
Research and development | (77,723 | ) | (12,082 | ) | - | (65,641 | ) | (60,244 | ) | (4,831 | ) | - | (55,413 | ) | |||||||||||||||||
General and administrative | (48,940 | ) | (18,045 | ) | - | (30,895 | ) | (26,851 | ) | (5,592 | ) | - | (21,259 | ) | |||||||||||||||||
Total operating expenses | (173,730 | ) | (38,772 | ) | - | (134,958 | ) | (124,674 | ) | (13,828 | ) | - | (110,846 | ) | |||||||||||||||||
Income (loss) from operations | $ | 107,009 | $ | (40,792 | ) | $ | - | $ | 147,801 | $ | 72,465 | $ | (14,666 | ) | $ | - | $ | 87,131 | |||||||||||||
Unrealized gain (loss) on short-term investments | (1,151 | ) | - | (1,151 | ) | - | (4,428 | ) | - | (4,428 | ) | - | |||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc. | $ | 72,547 | $ | (40,792 | ) | $ | (1,151 | ) | $ | 114,490 | $ | 59,649 | $ | (14,666 | ) | $ | (4,428 | ) | $ | 78,743 | |||||||||||
Basic EPS | $ | 1.17 | $ | 1.85 | $ | 0.99 | $ | 1.31 | |||||||||||||||||||||||
Diluted EPS | $ | 1.07 | $ | 1.70 | $ | 0.90 | $ | 1.19 |